Onderneming BioInvent International AB
Aandelen
BINV
SE0015244520
Biotechnologie & Medisch Onderzoek
Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
26 SEK | +2,77% | +11,59% | +37,13% |
11:45 | BioInvent kondigt evaluatie van Attana-technologie aan | CI |
24/04 | BioInvent International AB (publ) rapporteert resultaten voor het eerste kwartaal eindigend op 31 maart 2024 | CI |
Vakgebied
Aantal werknemers: 109
Verkoop per activiteit
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
100,0
%
| 326 | 100,0 % | 71 | 100,0 % | -78,09% |
Verkoop per regio
SEK in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
United States
66,3
%
| 273 | 83,8 % | 47 | 66,3 % | -82,66% |
Sweden
25,6
%
| 26 | 7,9 % | 18 | 25,6 % | -28,75% |
Europe
4,1
%
| 27 | 8,3 % | 3 | 4,1 % | -89,11% |
Other Countries
4,0
%
| - | - | 3 | 4,0 % | - |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Martin Welschof
CEO | Chief Executive Officer | 63 | 01-09-18 |
Stefan Ericsson
DFI | Director of Finance/CFO | 61 | 01-01-98 |
Marie Moores
COO | Chief Operating Officer | - | 01-02-22 |
Björn Frendéus
CTO | Chief Tech/Sci/R&D Officer | 51 | 01-01-01 |
Chief Tech/Sci/R&D Officer | 68 | 01-01-17 | |
Investor Relations Contact | - | 01-02-21 | |
Emma Meurling
HRO | Human Resources Officer | - | - |
General Counsel | - | 12-06-23 | |
Corporate Officer/Principal | - | 09-06-22 | |
Corporate Officer/Principal | 50 | 01-01-16 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Bernd Seizinger
BRD | Director/Board Member | 67 | 01-01-18 |
Leonard Kruimer
CHM | Chairman | 66 | 12-05-16 |
Vincent Ossipow
BRD | Director/Board Member | 55 | 12-05-16 |
Thomas O. Hecht
BRD | Director/Board Member | 73 | 03-07-20 |
Erik Esveld
BRD | Director/Board Member | - | 29-04-21 |
Director/Board Member | 49 | 12-07-22 | |
Director/Board Member | 56 | 01-01-18 | |
Natalie Berner
BRD | Director/Board Member | 34 | 12-07-22 |
Martin Pålsson
BRD | Director/Board Member | 45 | 01-01-22 |
Elin Birgersson
BRD | Director/Board Member | 39 | 01-01-23 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 65 804 362 | 57 013 147 ( 86,64 %) | 0 | 86,64 % |
Bedrijfsgegevens
BioInvent International AB
The Gamma Building Ideongatan 1
223 70, Lund
+46 4 62 86 85 50
http://www.bioinvent.comSector
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,13% | 152 mln. | |
-3,46% | 102 mld. | |
+1,41% | 96,29 mld. | |
+2,13% | 22,18 mld. | |
-15,84% | 21,2 mld. | |
-9,21% | 18,31 mld. | |
-39,98% | 17,38 mld. | |
-14,65% | 16,36 mld. | |
+4,39% | 13,97 mld. | |
+31,35% | 12,17 mld. |
- Beurs
- Aandelen
- Koers BINV
- Onderneming BioInvent International AB